Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00792428 · ClinicalTrials.gov registry record · NA

Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery

A NA study of Stroke and Cerebrovascular Accident, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT00792428: Completed NA study of Stroke and Cerebrovascular Accident, sponsored by Beth Israel Deaconess Medical Center.

NCT00792428 is a NA study of Stroke and Cerebrovascular Accident that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00792428, a NA study of Stroke and Cerebrovascular Accident, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a non-painful, non-invasive, brain-stimulation technique called transcranial direct current stimulation (tDCS) combined with traditional physical-occupational therapy (OT) will improve motor function in patients with chronic stroke. The aim is to determine the effect of applying real (anodal and/or cathodal) - in a dual configuration - vs sham (pretend) tDCS to the motor brain regions on both hemispheres - in a dual configuration - to improve motor function in chronic stroke patients. Our research in normal subjects has shown that motor skills can be enhanced if tDCS is applied to the brain's motor region during motor learning. The effects after a single session of tDCS can last for up to 30 minutes, effects of multiple sessions (one session per day) can last for weeks. Furthermore, single sessions of tDCS applied to the motor regions in stroke patients have shown that improvements in motor functions can be seen and that effects may last for at least 30 minutes. Patients enrolled in this trial will be randomized to receive either real tDCS or sham tDCS in combination with PT-OT once a day for 5 days. Assessments will be done about 3 days and 7 days after the end of the experimental treatment by investigators who are blinded to the intervention. Patients are also blinded as to whether they are receiving real or sham tDCS. We hypothesize that real tDCS applied to the motor regions in combination with PT-OT results in a subsequent improvement in motor function of the recovering hand over sham tDCS in combination with PT-OT.

Primary Outcome

This scale goes from 0 to 66 (max). Higher values are considered to be a better outcome.

Interventions

  • DEVICE Sham Transcranial Direct Current Stimulation
  • DEVICE Real Transcranial Direct Current Stimulation

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center / Harvard Medical School - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2006-06
Est. Completion 2013-02-01
Phase NA

What the finished NCT00792428 record still lists

NCT00792428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Sham Transcranial Direct Current Stimulation is the first listed.

NCT00792428 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00792428 about?

NCT00792428 is a clinical study titled "Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery". The purpose of this study is to determine whether a non-painful, non-invasive, brain-stimulation technique called transcranial direct current stimulation (tDCS) combined with traditional physical-occupational therapy (OT) will improve motor function in patients with chronic stroke. The aim is to det...

What is the current status of trial NCT00792428?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2006-06. Estimated completion is 2013-02-01.

What conditions does trial NCT00792428 study?

This clinical trial studies the following conditions: Stroke, Cerebrovascular Accident, Acute Stroke, CVA, Acute Cerebrovascular Accident.

What interventions are being tested in trial NCT00792428?

The interventions under investigation include: Sham Transcranial Direct Current Stimulation (DEVICE), Real Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00792428?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00792428 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00792428's enrollment target sits among peer trials

20 361st of 454 higher than 74 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00792428, the US trial registry maintained by the National Library of Medicine. NCT00792428 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.